Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells von Streicher, Wolfgang, Luedeke, Manuel, Azoitei, Anca, Zengerling, Friedemann, Herweg, Alexander, Genze, Felicitas, Schrader, Mark G, Schrader, Andres J, Cronauer, Marcus V

Volltext

Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection von Steinestel, Julie, Cronauer, Marcus V, Müller, Johannes, Al Ghazal, Andreas, Skowronek, Peter, Arndt, Annette, Kraft, Klaus, Schrader, Mark, Schrader, Andres J, Steinestel, Konrad

Volltext

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer von Schütz, Stefanie V, Schrader, Andres J, Zengerling, Friedemann, Genze, Felicitas, Cronauer, Marcus V, Schrader, Mark

Volltext

JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells von Laschak, Martin, Spindler, Klaus-Dieter, Schrader, Andres J, Hessenauer, Andrea, Streicher, Wolfgang, Schrader, Mark, Cronauer, Marcus V

Volltext

Detection of AR-V7 in primary prostate cancer von Kaczorowski, Adam, Chen, Xin, Kristiansen, Glen, Bernemann, Christof, Hohenfellner, Markus, Cronauer, Marcus V., Duensing, Stefan

Volltext

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines von CRONAUER, Marcus V, SCHULZ, Wolfgang A, BURCHARDT, Tatjana, ACKERMANN, Rolf, BURCHARDT, Martin

Volltext

Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful? von Rinnab, Ludwig, Schütz, Stefanie V., Diesch, Jeannine, Schmid, Evi, Küfer, Rainer, Hautmann, Richard E., Spindler, Klaus-Dieter, Cronauer, Marcus V.

Volltext

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer von Stein, Johannes, Krappe, Eliana, Kremer, Anika, Cronauer, Marcus V., Essler, Markus, Cox, Alexander, Klümper, Niklas, Krausewitz, Philipp, Ellinger, Jörg, Ritter, Manuel, Kristiansen, Glen, Majores, Michael

Volltext

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression von Van Goubergen, Jasper, Peřina, Miroslav, Handle, Florian, Morales, Elisa, Kremer, Anika, Schmidt, Oliver, Kristiansen, Glen, Cronauer, Marcus V, Santer, Frédéric R

Volltext

Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7 von Zengerling, Friedemann, Azoitei, Anca, Herweg, Alexander, Jentzmik, Florian, Cronauer, Marcus V.

Volltext

C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer von Azoitei, Anca, Merseburger, Axel S., Godau, Beate, Hoda, M. Raschid, Schmid, Evi, Cronauer, Marcus V.

Volltext

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer von Tolkach, Yuri, Kremer, Anika, Lotz, Gábor, Schmid, Matthias, Mayr, Thomas, Förster, Sarah, Garbe, Stephan, Hosni, Sana, Cronauer, Marcus V, Kocsmár, Ildikó, Kocsmár, Éva, Riesz, Péter, Alajati, Abdullah, Ritter, Manuel, Ellinger, Jörg, Ohlmann, Carsten-Henning, Kristiansen, Glen

Volltext

NF-κB signaling in prostate cancer: A promising therapeutic target? von Jain, Garima, Cronauer, Marcus V., Schrader, Mark, Möller, Peter, Marienfeld, Ralf B.

Volltext

Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy von Chen, Xin, Bernemann, Christof, Tolkach, Yuri, Heller, Martina, Nientiedt, Cathleen, Falkenstein, Michael, Herpel, Esther, Jenzer, Maximilian, Grüllich, Carsten, Jäger, Dirk, Sültmann, Holger, Duensing, Anette, Perner, Sven, Cronauer, Marcus V., Stephan, Carsten, Debus, Jürgen, Schrader, Andres Jan, Kristiansen, Glen, Hohenfellner, Markus, Duensing, Stefan

Volltext

The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells von Hupe, Marie C., Hoda, M. Raschid, Zengerling, Friedemann, Perner, Sven, Merseburger, Axel S., Cronauer, Marcus V.

Volltext

Re: Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-resistant Prostate Cancer Cell Lines von Schrader, Andres J, Schrader, Mark G, Cronauer, Marcus V

Volltext

A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder von SEIFERT, Hans-Helge, MEYER, Andrea, CRONAUER, Marcus V, HATINA, Jiri, MÜLLER, Mirko, RIEDER, Harald, HOFFMANN, Michele J, ACKERMANN, Rolf, SCHULZ, Wolfgang A

Volltext

Re: J. Alfred Witjes. A Case of Abiraterone Acetate Withdrawal. Eur Urol 2013;64:517–8 von Cronauer, Marcus V, Schrader, Mark G, Schrader, Andres J

Volltext

Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer von Schnoeller, Thomas, Jentzmik, Florian, Rinnab, Ludwig, Cronauer, Marcus V., Damjanoski, Ilija, Zengerling, Friedemann, Ghazal, Andreas Al, Schrader, Mark, Schrader, Andres J.

Volltext

Re: Christoph A. von Klot, Markus A. Kuczyk, Axel S. Merseburger. No Androgen Withdrawal Syndrome for Enzalutamide: A Report of Disease Dynamics in the Postchemotherapy Setting. Eu... von Schrader, Andres J, Schrader, Mark G, Cronauer, Marcus V

Volltext